Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial
Advanced BioDesign publishes its study in non-small cell lung cancer (NSCLC) in Oncogene
Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, for collaboration on adenosine receptor antagonists
Nosopharm obtains US patent for NOSO-502, a first-in-class novel antibiotic
Calixar launches new funding round to establish business strategy
Domain Therapeutics acquires Prestwick Chemical and Neurofit to bolster next stage of growth
PDC*line Pharma announces the administration of a first patient with its therapeutic cancer vaccine candidate (PDC*lung01) targeting non-small cell lung cancer
Advanced BioDesign raises additional €9 million from Xerys Funds
